The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Recommendation of "Moderate Buy" from Analysts

Key Points

• Seventeen analysts give Cooper Companies (NASDAQ:COO) a consensus rating of Moderate Buy with an average 12‑month target price of $90.79, while individual ratings range from one sell to one strong buy.
• In the most recent quarter (reported Mar 5) Cooper beat EPS estimates ($1.10 vs. $1.03), delivered $1.02B in revenue (up 6.2% YoY), and issued Q2 2026 EPS guidance of 4.580–4.660 versus analyst expectations of ~3.98 for the year.
• Major institutional investors materially increased positions (notably Wellington, Generation Investment, Diamond Hill, JANA and T. Rowe), leaving institutional ownership at 24.39%.

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seventeen analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $90.7857.

Several research analysts have recently issued reports on COO shares. KeyCorp reiterated a "sector weight" rating on shares of Cooper Companies in a report on Friday, December 5th. Needham & Company LLC boosted their target price on Cooper Companies from $99.00 to $101.00 and gave the stock a "buy" rating in a report on Friday, March 6th. William Blair upgraded Cooper Companies to a "strong-buy" rating in a research report on Friday, January 30th. The Goldman Sachs Group reaffirmed a "sell" rating and set a $73.00 price target on shares of Cooper Companies in a research note on Friday, January 9th. Finally, Piper Sandler reiterated an "overweight" rating and set a $94.00 price target (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $70.17 on Friday. Cooper Companies has a fifty-two week low of $61.78 and a fifty-two week high of $89.83. The firm's 50-day simple moving average is $77.68 and its 200 day simple moving average is $76.22. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The stock has a market cap of $13.69 billion, a P/E ratio of 34.74, a P/E/G ratio of 1.81 and a beta of 1.07.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies's revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities analysts expect that Cooper Companies will post 3.98 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of COO. Wellington Management Group LLP boosted its position in shares of Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company's stock valued at $424,043,000 after purchasing an additional 4,756,178 shares in the last quarter. Generation Investment Management LLP bought a new stake in shares of Cooper Companies in the 4th quarter worth approximately $233,539,000. Diamond Hill Capital Management Inc. lifted its stake in Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company's stock valued at $269,471,000 after purchasing an additional 2,720,594 shares during the last quarter. JANA Partners Management LP acquired a new stake in Cooper Companies during the third quarter valued at approximately $166,917,000. Finally, Price T Rowe Associates Inc. MD boosted its holdings in Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company's stock worth $494,123,000 after buying an additional 2,231,568 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Company Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.